PharmaJet Announces Scientific Advisory Boards and Presentation at World Vaccine Congress in Washington on April 1
PharmaJet Begin Implementation of Study Using Tropis ID for Routine Immunization
PharmaJet Partner, Scancell, Announces Positive Data from the First Stage of its Phase 2 Trial of Advanced Melanoma DNA Vaccine delivered Needle-free
GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet,® a company engineering Precision Delivery Systems™ that overcome the challenges of vaccines and pharmaceuticals delivery, today announced that Nanette Cocero, Ph.D., has been appointed to its Board of Directors. Dr. Cocero is a recognized leader in the global pharmaceutical industry with broad commercial and business experience coupled with an extensive clinical and scientific background.
GOLDEN, Colo.--(BUSINESS WIRE)--PharmaJet,® a company engineering Precision Delivery Systems™ that overcome the challenges of vaccines and pharmaceuticals delivery, today announced that Marie Mazur, PharmD, has been appointed Chair of the Board of Directors. She replaces Ron Lowy who had chaired the Board since 2011.
PharmaJet, a US-based company engineering precision delivery systems that overcome the challenges of vaccine delivery, has announced its support for the World Health Organisation’s (WHO) polio eradication campaigns in Pakistan starting in May 2023.
PharmaJet Announces U.S. Government Award Expansion to Clinically Assess a DNA Vaccine Combined with its Systems
PharmaJet Partner Gennova Biopharmaceuticals Seeks Emergency Use Authorization in India for the First Needle-Free mRNA Vaccine Omicron Booster
PharmaJet Announces Clinical Results from Scancell’s COVID-19 DNA Vaccine Study Exclusively Administered with Their Needle-free Precision Delivery Systems
Review Highlights Growing Evidence That PharmaJet’s Precision Delivery Devices Improve Nucleic Acid Vaccine Performance